Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific manner. [electronic resource]
Producer: 20121017Description: 49-56 p. digitalISSN:- 1527-3350
- Adult
- Aged
- Albumins -- therapeutic use
- Antiviral Agents -- therapeutic use
- Cholesterol -- genetics
- Chromatography, Gas
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon-alpha -- therapeutic use
- Lanosterol -- genetics
- Lipid Metabolism -- drug effects
- Male
- Mass Spectrometry
- Middle Aged
- Oxidative Stress -- genetics
- Pilot Projects
- Prognosis
- Ribavirin -- therapeutic use
- Risk Assessment
- Severity of Illness Index
- Signal Transduction -- genetics
- Statistics, Nonparametric
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.